Congenital Lipomatous Overgrowth, Vascular Malformations, and Epidermal Nevi

A congenital syndrome characterized by prenatal overgrowth, hemihypertrophy and facial asymmetry, multiple vascular malformations, splenic cysts, skeletal abnormalities, and epidermal nevi. It is caused by somatic mosaic mutations in the PHOSPHOINOSITIDE 3-HYDROXYKINASE alpha peptide (PIK3CA) gene. OMIM: 612918

Also Known As:

Clove Syndrome; Cloves Syndrome; Congenital Lipomatous Overgrowth, Vascular Malformations, Epidermal Nevi, and Skeletal-Spinal Abnormalities

Neoplasms: 1361496
- Neoplasms by Histologic Type: 2
  - Nevi and Melanomas: 63
    - Nevus: 2344
      - Congenital Lipomatous Overgrowth, Vascular Malformations, and Epidermal Nevi: 13
  - Connective and Soft Tissue Neoplasms: 1
    - Adipose Tissue Neoplasms: 1
      - Lipoma: 1365
        Congenital Lipomatous Overgrowth, Vascular Malformations, and Epidermal Nevi: 13
Musculoskeletal Diseases: 751
- Musculoskeletal Abnormalities: 46
  - Congenital Lipomatous Overgrowth, Vascular Malformations, and Epidermal Nevi: 13
Congenital, Hereditary, and Neonatal Diseases and Abnormalities: 960
- Congenital Abnormalities: 26404
  - Cardiovascular Abnormalities: 457
    - Vascular Malformations: 1473
      - Congenital Lipomatous Overgrowth, Vascular Malformations, and Epidermal Nevi: 13
  - Musculoskeletal Abnormalities: 46
    - Congenital Lipomatous Overgrowth, Vascular Malformations, and Epidermal Nevi: 13
Cardiovascular Diseases: 94258
- Cardiovascular Abnormalities: 457
  - Vascular Malformations: 1473
    - Congenital Lipomatous Overgrowth, Vascular Malformations, and Epidermal Nevi: 13

Rocío Lizarraga Selected Research

Rocío Lizarraga Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure